Legg-Perthes disease-like joint involvement and diagnosis delay in Scheie syndrome: a case report
- PMID: 17264973
- DOI: 10.1007/s10067-007-0549-6
Legg-Perthes disease-like joint involvement and diagnosis delay in Scheie syndrome: a case report
Abstract
Mucopolysaccharidosis (MPS) type I is an inherited disease caused by the absence or malfunctioning of lysosomal enzymes. Three subtypes, based on severity of symptoms, were described, and Scheie syndrome (also called MPS I S) is the mildest form. Although there may be some typical extra-articular manifestations, musculoskeletal involvement may be the only presenting sign in the absence of other symptoms in the patients with less severe forms. The patients with MPS I S, especially in attenuated phenotypes, may be sometimes difficult to recognize for physicians not familiar with the disease. With this case presentation, it is aimed to draw attention to this disease, which could be delayed for the correct diagnosis. An increased awareness of the disease may contribute to more accurate diagnosis, and patients may benefit from early intervention.
Similar articles
-
Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome.Clin Exp Rheumatol. 2006 Mar-Apr;24(2):196-202. Clin Exp Rheumatol. 2006. PMID: 16762159
-
Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of Scheie syndrome: Three cases from the same family.Turk J Pediatr. 2018;60(3):344-347. doi: 10.24953/turkjped.2018.03.020. Turk J Pediatr. 2018. PMID: 30511553
-
Mucopolysaccharidosis type-IS presenting with onset of carpal tunnel syndrome at adolescence.J Clin Rheumatol. 2009 Dec;15(8):402-4. doi: 10.1097/RHU.0b013e3181bedf12. J Clin Rheumatol. 2009. PMID: 19955999
-
Non-cartilaginous metaphyseal cysts in Legg-Calvé-Perthes disease: report of a case.Pediatr Radiol. 1997 Oct;27(10):824-6. doi: 10.1007/s002470050245. Pediatr Radiol. 1997. PMID: 9323253 Review.
-
Mucopolysaccharidosis type I.Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6. Pediatr Endocrinol Rev. 2014. PMID: 25345091 Review.
Cited by
-
Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging.Front Med (Lausanne). 2024 Jan 19;10:1252704. doi: 10.3389/fmed.2023.1252704. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38314027 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources